Bivalirudin is indicated to reduce the risk of acute ischemic complications, for example death due to myocardial infarction or need for urgent revascularization procedures, in patients with unstable angina pectoris undergoing percutaneous coronary intervention (PCI). If indicated, the therapy may be continued for up to 4 hours after termination of PCI
Features
.CAS No:128270-60-0Main Products
Desmopressin Acetate,Eptifibatide,Bivalirudin